Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Bora Pharmaceuticals’ Bobby Sheng wins ‘CEO of the Year’ at CPhI Awards 2020

    Oct 15, 2020, 12:49 PM by Abhinav Singh
    - Oct 15, 2020 - Bora Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO) which specialises in immediate and modified-release tablets and capsules, along with serialised packaging, announced that its Chairman and CEO, Bobby Sheng, was unveiled as ‘CEO of the Year’ at the CPhI Pharma Awards 2020
    Full story
  • Dotmatics introduces Blueprint to provide self-service data analysis for medicinal and synthetic chemists

    Oct 15, 2020, 08:35 AM by Abhinav Singh
    BISHOP'S STORTFORD, UNITED KINGDOM - Oct 14, 2020 - Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has expanded its product portfolio to include Blueprint, a self-service, scientific visualization and analytics application for small molecule discovery
    Full story
  • Proving The Value Of Preventive Genomics

    Oct 15, 2020, 01:35 AM by Michael Croft
    Bio-IT World | The Bio-IT World Conference & Expo closed out with a plenary keynote presentation on preventive genomics by Robert Green, M.D., professor of medicine at Harvard Medical School and a physician-scientist who directs the G2P Research Program at Brigham and Women’s Hospital and the Broad Institute. Data-sharing difficulties were a recurring theme at this year’s conference but, as the COVID-19 Host Genetics Initiative has demonstrated, it is possible to combine genomic data to rapidly explore markers of disease, he says.
    Full story
  • AffaMed Therapeutics Announces Merger with EverInsight Therapeutics and Appoints Dayao Zhao, M.D., Ph.D. as CEO

    Oct 14, 2020, 15:50 PM by Abhinav Singh
    BELFORD, NJ, UNITED STATES - Oct 14, 2020 - SHANGHAI, China, Oct. 14, 2020 (GLOBE NEWSWIRE) -- AffaMed Therapeutics (“AffaMed”), a biopharmaceutical company focused on developing and commercializing transformative therapeutics to address ophthalmologic and central nervous system (CNS) disorders with high unmet medical need for patients in Greater China and beyond, today announced a definitive merger agreement with biopharmaceutical company EverInsight Therapeutics (“EverInsight”)
    Full story
  • Partek Genomic Analysis Software Reaches New Citation High: Over 8,000 Peer-reviewed Articles

    Oct 14, 2020, 14:29 PM by Abhinav Singh
    ST. LOUIS, MO, UNITED STATES - Oct 15, 2020 -   Partek Incorporated announced today that its software has been cited in over eight thousand peer-reviewed articles published in scientific journals, including the prestigious PNAS, Cell, and Nature Medicine  journals
    Full story
  • New Healthcare Consumer Survey Shows Continued Rise in Demand for Digital Access and Catalytic Impact of the COVID-19 Pandemic

    Oct 14, 2020, 09:42 AM by Abhinav Singh
    BOSTON, MA, UNITED STATES - Oct 14, 2020 - Kyruus today announced findings from its fourth annual survey of 1,000 healthcare consumers exploring how they learn about, select, and schedule appointments with new providers
    Full story
  • Momentum for AVIA Members Strong as Digital Transformation Accelerates

    Oct 14, 2020, 09:34 AM by Abhinav Singh
    CHICAGO, MA, UNITED STATES - Oct 14, 2020 - While hospitals and health systems across the country face tremendous financial pressures and declining consumer confidence, AVIA Network Members continue to lead healthcare toward practical, impactful, and sustainable digital transformation
    Full story
  • Researcher-Driven Data Stewardship, Storage: Trends from the Trenches 2020

    Oct 14, 2020, 01:50 AM by Michael Croft
    Bio-IT World  | On its 10th anniversary, the annual Trends from the Trenches presentation from Chris Dagdigian, co-founder and principle consultant of BioTeam, and friends had lost none of its characteristic candor and punch—even in a virtual environment and even as Dagdigian successfully continued to limit his own speaking time.
    Full story
  • WCG Leads the Way and Sets a New Standard - Announcing the Formation of WCG IRB and the Launch of New WCG IRB Connexus™

    Oct 12, 2020, 14:37 PM by Abhinav Singh
    PRINCETON, NJ - Oct 12, 2020 - WCG announced today the unification of its five industry-leading IRBs – Western IRB (WIRB), Copernicus Group IRB (CGIRB), Midlands IRB (MLIRB), New England IRB (NEIRB), and Aspire IRB – into the single WCG IRB brand
    Full story
  • Mogrify introduces EpiMOGRIFY platform to systematically identify epigenetic switches driving cell identity and cell maintenance

    Oct 12, 2020, 09:15 AM by Abhinav Singh
    CAMBRIDGE, UNITED KINGDOM - Dec 10, 2020 - Cambridge, UK, 9th October 2020: Mogrify Limited (Mogrify®), a UK company aiming to transform the development of ex vivo cell therapies and pioneer the field of in vivo reprogramming therapies, today announced the introduction of EpiMOGRIFY
    Full story
  • Study Shows Proof of Concept of BioIVT HEPATOPAC Cultures with Targeted Assay to Evaluate Bioactivation Potential and Drug-induced Liver Injury (DILI) Risk

    Oct 12, 2020, 08:14 AM by Abhinav Singh
    WESTBURY, NY - Oct 12, 2020 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the publication of research describing the use of HEPATOPAC® cultures with a targeted in vitro assay to identify small molecule drugs with high potential for drug-induced liver injury (DILI)
    Full story
  • The Great Data Science Promise For COVID-19, Opioid Addiction

    Oct 12, 2020, 02:15 AM by Michael Croft
    Bio-IT World | The Bio-IT World Conference & Expo Virtual launched last week with an opening plenary keynote from Drs. Susan Gregurick, Associate Director for Data Science at NIH and Rebecca Baker, Director of the HEAL Initiative at NIH.
    Full story
  • Alfa Chemistry Materials Offers Wide Options of Resins for Decoration or Manufacture of Plastics

    Oct 10, 2020, 01:53 AM by Abhinav Singh
    NY, NY - Oct 10, 2020 - On October 8, 2020, Alfa Chemistry Materials announces to provide wide options of resins for customers worldwide, which have broad applications in decoration, manufacture of plastics as well as other fields
    Full story
  • Novel T Cell Subset, Nitric Oxide Effective Treatment Option, SoCal cases linked to New York: COVID-19 Updates

    Oct 9, 2020, 04:50 AM by Michael Croft
    Bio-IT World | MIT’s preprint reviewers debunk synthetic SARS-CoV-2 paper, genetic analysis of virus samples show most COVID-19 cases in Southern California early in the pandemic are linked to New York state via Europe, not directly from China, vaccines should not be affected by the dominant ‘G-strain’, severe cases of COVID-19 develop a novel T cell subset that can potentially kill B cells, and MS drug inhibits virus growth. Plus, NIH funds COVID-10 vaccine using bovine adenovirus.
    Full story
  • Abzena invests $60m into cGMP manufacturing capacity

    Oct 8, 2020, 15:15 PM by Abhinav Singh
    SAN DIEGO, CA, UNITED KINGDOM - Oct 8, 2020 - Leading contract provider of integrated discovery, development and manufacturing services for biologics and bioconjugates, Abzena, has invested $60m into a new facility for late phase and commercial cGMP manufacturing
    Full story
  • Bio-IT World Virtual: Gamifying Discovery, Human-in-the-Loop AI, New Data Commons Model

    Oct 7, 2020, 19:00 PM by Michael Croft
    Bio-IT World  Day two of the Bio-IT World Conference & Expo Virtual was highlighted by a plenary keynote on artificial intelligence (AI) and citizen science, a new data commons maturity model, guidance for FAIRifying data, augmented intelligence systems for biological data, and much more. 
    Full story
  • Solentim to supply cell line development solutions for Samsung Biologics’ new R&D center in San Francisco

    Oct 7, 2020, 05:07 AM by Michael Croft
    BOURNEMOUTH, UNITED KINGDOM - Oct 7, 2020 - Solentim is pleased to announce the adoption of its VIPS™ single cell seeding platform and Cell Metric® CLD into Samsung Biologics’ new research and development facility in San Francisco, CA
    Full story
  • Sandia helps safeguard biological data threatened during COVID-19 pandemic

    Oct 7, 2020, 02:10 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Oct 6, 2020 - A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment has become more relevant after the United States and others issued warnings that hackers were using the COVID-19 pandemic to increase their activities
    Full story
  • Bio-IT World Virtual: First Plenary, AI Workshops, Globus For Data Transfer

    Oct 6, 2020, 19:15 PM by Michael Croft
    Bio-IT World  The Bio-IT World Conference & Expo Virtual launched today with an open plenary keynote from Drs. Susan Gregurick, Associate Director for Data Science at NIH and Rebecca Baker, Director of the HEAL Initiative at NIH. The rest of the day was full of workshops covering AI in clinical trials and drug discovery, tools for moving data quickly and safely, wearables to gather data, and much more.
    Full story
  • NVIDIA and PetaGene Combine Genomic Technologies to Address Critical Analysis Bottlenecks

    Oct 6, 2020, 17:15 PM by Michael Croft
    CAMBRIDGE, UK - Oct 6, 2020 - PetaGene and NVIDIA announce seamless integration of PetaGene's PetaSuite tools as a standard part of NVIDIA Clara Parabricks Pipelinesx
    Full story
  • «
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy